FAQs for PrEPVacc's vaccine result IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc5 August 2024
Media coverage of PrEPVacc's July 2024 vaccine result announcement IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc23 July 2024Media
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc23 July 2024Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda MRC/UVRI and LSHTM UgandaPrEP Vacc23 July 2024Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc23 July 2024Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement MRC/UVRI and LSHTM UgandaPrEP Vacc23 July 2024Research
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc11 January 2024
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports IMPERIAL, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc4 December 2023
STAT: 'Can the world still invent an HIV vaccine? Progress in one area creates new problem' MRC/UVRI and LSHTM UgandaPrEP Vacc2 October 2023Media
CNN reports on ‘the last roll of the dice’ for an HIV vaccine this decade IMPERIAL, MRC/UVRI and LSHTM Uganda, SAMRCPrEP Vacc27 August 2023Media
News Release: African-led PrEPVacc HIV prevention study completes its enrolment IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc9 June 2023
Video to help inform PrEPVacc participants posted online IMPERIAL, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc31 March 2023
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda MRC/UVRI and LSHTM UgandaPrEP Vacc14 September 2022Research
Getty photographer visits PrEPVacc site at Masaka MRC/UVRI and LSHTM UgandaPrEP Vacc25 March 2022Media
PrEPVacc featured in December 2021 'Science et Vie' magazine cover story MRC/UVRI and LSHTM UgandaPrEP Vacc23 December 2021Media
‘African scientists should lead in developing an Aids jab for Africa’ MRC/UVRI and LSHTM UgandaPrEP Vacc1 December 2021Media
PrEPVacc featured in JIAS articles in Nov 2021 IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc30 November 2021
Study leaders congratulate PrEPVacc teams on opening all trial sites IMPERIAL, MRC/UVRI and LSHTM UgandaPrEP Vacc5 October 2021
Activists push for continuity of HIV vaccine research MRC/UVRI and LSHTM UgandaPrEP Vacc23 September 2021Media
Mbeya begins enrolment to PrEPVacc clinical trial NIMR-MMRC, MRC/UVRI and LSHTM UgandaPrEP Vacc29 July 2021
